SARTORIUS STED BIO (EPA:DIM) | WebDisclosure

Basculer en Français

11280	Companies
250631	Keywords
179289	Articles
136459	Press releases

Home
Companies
SARTORIUS STED BIO

PRESS RELEASE

published on 04/18/2024 at 07:02, 2 years 6 months ago

Sartorius Stedim Biotech publie ses résultats non audités pour le premier trimestre 2024
Sartorius Stedim Biotech publie ses résultats non audités pour le premier trimestre 2024 avec un chiffre d'affaires en baisse de 9,4%, des prises de commandes en progression et des prévisions confirmées malgré l'incertitude mondiale

Chiffre D'affaires Sartorius Stedim Biotech Prises De Commandes Résultat Trimestriel Prévisions
PRESS RELEASE

published on 04/18/2024 at 07:02, 2 years 6 months ago

Sartorius Stedim Biotech publishes unaudited first quarter results for 2024
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024, showing sales revenue of 667 million euros and order intake up 13.9 percent. Full-year outlook confirmed amidst global uncertainties

Order Intake Sartorius Stedim Biotech Sales Revenue First Quarter Results Full-year Outlook
BRIEF

published on 04/02/2024 at 15:40, 2 years 7 months ago

Sartorius Stedim Biotech annonce sa structure en capital et droits de vote pour Mars 2024

Droits De Vote Capital Social Actions Sartorius Stedim Biotech Transparence
BRIEF

published on 04/02/2024 at 15:40, 2 years 7 months ago

Sartorius Stedim Biotech announces its capital structure and voting rights for March 2024

Share Capital Voting Rights Actions Transparency Sartorius Stedim Biotech
PRESS RELEASE

published on 04/02/2024 at 15:35, 2 years 7 months ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Sartorius Stedim Biotech SA a publié une déclaration concernant le nombre d'actions et de droits de vote composant son capital social. Les détails réglementaires sont disponibles dans le communiqué officiel

Déclaration Droits De Vote Capital Social Actions Sartorius Stedim Biotech SA
PRESS RELEASE

published on 04/02/2024 at 15:35, 2 years 7 months ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital as of March 31, 2024. This announcement complies with relevant regulatory requirements

Voting Rights Shares Sartorius Stedim Biotech SA Regulatory Announcement Issued Capital
BRIEF

published on 03/26/2024 at 16:23, 2 years 7 months ago

Resolutions Passed at Sartorius Stedim Biotech's Annual Shareholders’ Meeting

Board Of Directors Dividend Sartorius Stedim Biotech Biopharmaceutical Industry Annual Shareholders’ Meeting
BRIEF

published on 03/26/2024 at 16:23, 2 years 7 months ago

Résolutions adoptées lors de l'assemblée générale annuelle des actionnaires de Sartorius Stedim Biotech

Conseil D'administration Dividende Industrie Biopharmaceutique Assemblée Générale Annuelle Sartorius Stedim Biotechnologie
PRESS RELEASE

published on 03/26/2024 at 16:18, 2 years 7 months ago

Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A. shareholders approve resolutions and dividend proposal at Annual Shareholders' Meeting. Board composition updated

Dividend Proposal Sartorius Stedim Biotech S.A. Resolutions Annual Shareholders' Meeting Board Composition
PRESS RELEASE

published on 03/26/2024 at 16:18, 2 years 7 months ago

Résolutions de l’Assemblée générale annuelle mixte de Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech annonce les résolutions de son Assemblée Générale annuelle mixte, approuve le dividend et renouvelle la nomination de deux administratrices pour 3 ans

Assemblée Générale Sartorius Stedim Biotech Dividende Resolutions Administration

Accesswire

Published on 11/04/2026 at 23:10, 8 hours 8 minutes ago

Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 8 hours 18 minutes ago

Avino Reports Q3 2026 Financial Results
Published on 11/04/2026 at 23:00, 8 hours 18 minutes ago

Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 9 hours 3 minutes ago

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 9 hours 13 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/05/2026 at 07:05, 13 minutes ago

PolyPeptide Group: Definitive end result of the public tender offer of Samsung Biologics Co., Ltd.
Published on 11/05/2026 at 07:05, 13 minutes ago

EDAG Engineering Group AG: Profitability significantly improved in the first nine months of 2026
Published on 11/05/2026 at 07:02, 16 minutes ago

Commerzbank delivers best nine-month result in its history
Published on 11/05/2026 at 07:00, 18 minutes ago

Private Equity Holding AG: Half Year-Report as of September 30, 2026
Published on 11/05/2026 at 07:00, 18 minutes ago

Rational continues on growth trajectory and confirms profit forecast for 2026

Les Echos

Published on 11/05/2026 at 07:00, 18 minutes ago

Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Published on 11/05/2026 at 07:00, 18 minutes ago

Eurazeo’s European asset management platform continues to gain momentum, driven by sustained international fundraising
Published on 11/05/2026 at 07:00, 18 minutes ago

Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
Published on 11/05/2026 at 07:00, 18 minutes ago

Eurazeo confirme la dynamique de sa plateforme européenne de gestion d’actifs, portée par une collecte internationale soutenue
Published on 11/04/2026 at 18:00, 13 hours 18 minutes ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026

View all LES ECHOS COMFI WIRE